Global API Contract Manufacturing Market, By Type (Organic, Inorganic, Others), Volume (Low, Large, Medium, Others), Form (Solid, Liquid, Semi-Solids, Others) End-Users (Pharmaceutical Industries, Research Organization, Others), Distribution Channel (Direct Tender, Retailers, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global API Contract Manufacturing Market
Global API contract manufacturing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 9.90% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.
Technological advancement in production of API which is proven to be highly effective in meeting regulatory requirements and high demand for novel bio-generic drugs also boost up the market growth. Moreover, increasing demand for cost-efficient therapeutics in developing regions and increase in approval of new drugs for treatment of chronic diseases act as an opportunity for the market growth. However, long process for manufacturing and stringent rules & regulations in relation to facilities and equipment required for sterile small-molecule drugs, may hamper the global API contract manufacturing market.
For 2017, the API contract manufacturing market alone is estimated at about $70-75 billion including clinical supplies, active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).
This API contract manufacturing market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global API Contract Manufacturing Market Scope and Market Size
The API contract manufacturing market is segmented on the basis of type, volume, form end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the API contract manufacturing market is segmented into organic, inorganic, and others.
- On the basis of volume, the API contract manufacturing market is segmented into low, large, medium and others.
- On the basis of form, the API contract manufacturing market is segmented into solid, liquid, semi solids and others.
- On the basis of end-users, the API contract manufacturing market is segmented into pharmaceutical industries, research organization and others.
- On the basis of distribution channel, the API contract manufacturing market has also been segmented into direct tender, retailers and others.
API Contract Manufacturing Market Country Level Analysis
API contract manufacturing market is analysed and market size information is provided by country, type, volume, form, end-users and distribution channel as referenced above.
The countries covered in the API contract manufacturing market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share in API contract manufacturing market due to the presence of high healthcare expenditure and rising requirement for new bio-generic drugs. Asia-Pacific is expected to account for the largest market share over coming years for the API contract manufacturing market due to reduced cost of production of APIs, availability of required skilled labour at an effective cost, favorable government policies, tax benefits and better trade relationships.
The country section of the API contract manufacturing market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and API Contract Manufacturing Market Share Analysis
API contract manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to API contract manufacturing market.
The major players covered in the API contract manufacturing market are Teva Pharmaceuticals Industries Ltd, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Piramal Pharma Solutions, Sandoz AG, GlaxoSmithKline Plc., Lupin, and Juniper Pharmaceutical among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
